ATE86485T1 - Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen. - Google Patents

Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen.

Info

Publication number
ATE86485T1
ATE86485T1 AT90401205T AT90401205T ATE86485T1 AT E86485 T1 ATE86485 T1 AT E86485T1 AT 90401205 T AT90401205 T AT 90401205T AT 90401205 T AT90401205 T AT 90401205T AT E86485 T1 ATE86485 T1 AT E86485T1
Authority
AT
Austria
Prior art keywords
aromatic
derivatives
treatment
image
aminoalcoxy
Prior art date
Application number
AT90401205T
Other languages
English (en)
Inventor
Bernard Pourrias
Mona Ward
Raphael Santamaria
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande Sa filed Critical Delalande Sa
Application granted granted Critical
Publication of ATE86485T1 publication Critical patent/ATE86485T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
AT90401205T 1989-05-05 1990-05-04 Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen. ATE86485T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8905988A FR2646670A1 (fr) 1989-05-05 1989-05-05 Utilisation de derives aminoalkoxy aromatiques pour le traitement des troubles du systeme cerebrovasculaire
EP90401205A EP0396474B1 (de) 1989-05-05 1990-05-04 Verwendung von aromatischen Aminoalkoxyderivaten zur Behandlung zerebrovaskulärer Störungen

Publications (1)

Publication Number Publication Date
ATE86485T1 true ATE86485T1 (de) 1993-03-15

Family

ID=9381445

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90401205T ATE86485T1 (de) 1989-05-05 1990-05-04 Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen.

Country Status (6)

Country Link
US (1) US5132302A (de)
EP (1) EP0396474B1 (de)
JP (1) JPH02295920A (de)
AT (1) ATE86485T1 (de)
DE (1) DE69001038T2 (de)
FR (1) FR2646670A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
AUPS110302A0 (en) * 2002-03-14 2002-04-18 Biomolecular Research Institute Limited Novel chalcone derivatives and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78370B (de) * 1981-12-24 1984-09-26 Delalande Sa
FR2518992A1 (fr) * 1981-12-24 1983-07-01 Delalande Sa Nouveaux derives aminoalcoxy aromatiques, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
DE69001038T2 (de) 1993-08-05
FR2646670A1 (fr) 1990-11-09
EP0396474A1 (de) 1990-11-07
DE69001038D1 (de) 1993-04-15
EP0396474B1 (de) 1993-03-10
JPH02295920A (ja) 1990-12-06
US5132302A (en) 1992-07-21

Similar Documents

Publication Publication Date Title
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
ATE206919T1 (de) Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen
DE69009684D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
MX9200063A (es) Derivados de acidos tetrahidrofolicos y procedimiento para su preparacion.
ATE162715T1 (de) Verwendung von schwefel enthaltenden carbonsäuren zur bekämpfung von pathophysiologisch bedingten erregungsstörungen
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ES2141787T3 (es) Derivados de la 1,2,3,4-tetrahidro-9-acridinamina.
ATE23674T1 (de) Fussgeraet zur behandlung der reflexzonen der fuesse und besonders von von rueckgratverunstaltungen verursachten stoerungen und leiden.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
SE8505219D0 (sv) Derives aminoalkoxy aromatiques et leur procede de preparation
ATE86485T1 (de) Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen.
DE59206403D1 (de) Verwendung von Xanthinderivaten zur Herstellung eines Arzneimittels zur Behandlung von sekundären Nervenzellschäden und Funktionsstörungen nach Schädel-Hirn-Traumen
DE69209128D1 (de) Verwendung von Indazol-Methoxyalkansäure zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunkrankheiten
MX10554A (es) 9-etil-6,9-dihidro-4,6 dioxo-10-propil-4h-pirano [3,2-q]-quinolina-2,8-dicarboxilato de calcio, y procedimiento para su preparacion
ATE31022T1 (de) Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten.
DE69415757D1 (de) Zusammensetzung zur Vorbeugung und Behandlung von Myopie
ATE73997T1 (de) Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.
ATE28878T1 (de) Neue 6alpha-methylprednisolon-derivate ihre herstellung und verwendung.
ES501744A0 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas
MX9204423A (es) Medicamento que contiene antagonistas de calcio y procedimiento para su fabricacion.
RU94011634A (ru) Стимулятор для выведения картофельной нематоды из цисты, способ его получения и препаративная форма на его основе
ATE15891T1 (de) 1-alkyl-2-isocyanatomethyl-isocyanato-benzole und/oder 1-alkyl-4-isocyanatomethyl-isocyanatobenzole, verfahren zu deren herstellung und verwendung.
IT8603418A1 (it) Calzatura anatomica per la prevenzione e la correzione dell'alluce valgo.
AT388376B (de) Verfahren zur herstellung von neuen benzolsulfonamiden und deren salzen

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee